Product
10-1074
2 clinical trials
1 indication
Indication
HIV InfectionClinical trial
A Phase I Clinical Trial of the Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment InterruptionStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibodies VRC01LS and 10-1074 on Maintenance of HIV Suppression in a Cohort of Early-Treated Children in Botswana (Dual bNAb Treatment in Children)Status: Completed, Estimated PCD: 2021-12-03